Morning Sickness and Nausea Pellets
- Manufacturer
- Legendairy Milk | Newton Laboratories, Inc.
- Effective date
- 2022-09-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:54:05
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Formulated for associated symptoms such as dizziness, discomfort, indigestion, nausea, vomiting and loss of appetite.
DOSAGE & ADMINISTRATION SECTION
Directions: Adults: On your first day of taking the remedy, take 3 pellets under the tongue every 30 minutes for 6 doses beginning at the onset of symptoms. If you feel that your symptoms are not improving, increase frequency to 3 pellets every 15 minutes. Once symptoms start improving, stop treatment.
OTC - ACTIVE INGREDIENT SECTION
Equal parts of Chamomilla 6x, Hydrastis 6x, Iris ver. 6x, Bismuth. met. 15x, Bryonia 15x, Cimicifuga 15x, Gossypium 15x, Ipecac. 15x, Kreosotum 15x, Lycopodium 15x, Mag. carb. 15x, Nux vom. 15x, Pulsatilla 15x, Sepia 15x, Symphoricarpus 15x, Tabacum 15x, Zingiber 15x.
OTC - PURPOSE SECTION
Formulated for associated symptoms such as dizziness, discomfort, indigestion, nausea, vomiting and loss of appetite.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, Non-GMO, organic beet-derived sucrose (lactose-free) pellets.
QUESTIONS SECTION
Distributed by Legendairy Milk - Question? 512.240.2655
1007 S. Heatherwild Blvd., Unit 100
Pflugerville, TX 78660
WARNINGS SECTION
WARNINGS: Keep out of reach of children. Do not use if tamper-evident seal is broken or missing. If symptoms worsen or persist for more than a few days, consult a doctor. If pregnant or breast-feeding, ask a doctor before use.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a doctor before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
Products#
Every source-derived product name is available through these pages.
- Morning Sickness and Nausea Pellets
- Chamomilla, Hydrastis canadensis, Iris versicolor, Bismuthum metallicum, Bryonia, Cimicifuga racemosa, Gossypium herbaceum, Ipecacuanha, Kreosotum, Lycopodium clavatum, Magnesia carbonica, Nux vomica, Pulsatilla, Sepia, Symphoricarpus racemosus, Tabacum, Zingiber officinale.
- SUCROSE
- IRIS VERSICOLOR ROOT
- BISMUTH
- BRYONIA ALBA ROOT
- BLACK COHOSH
- GOSSYPIUM HERBACEUM ROOT BARK
- IPECAC
- WOOD CREOSOTE
- LYCOPODIUM CLAVATUM SPORE
- MAGNESIUM CARBONATE
- CARBONATE ION
- STRYCHNOS NUX-VOMICA SEED
- MATRICARIA CHAMOMILLA
- SEPIA OFFICINALIS JUICE
- SYMPHORICARPOS ALBUS FRUIT
- TOBACCO LEAF
- GINGER
- GOLDENSEAL
- ANEMONE PULSATILLA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82952-0001 | 82952-0001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUCROSE | C151H8M554 | IACT |
| IRIS VERSICOLOR ROOT | X43D4L3DQC | ACTIB |
| BISMUTH | U015TT5I8H | ACTIB |
| BRYONIA ALBA ROOT | T7J046YI2B | ACTIB |
| BLACK COHOSH | K73E24S6X9 | ACTIB |
| GOSSYPIUM HERBACEUM ROOT BARK | VQN1631P4C | ACTIB |
| IPECAC | 62I3C8233L | ACTIB |
| WOOD CREOSOTE | 3JYG22FD73 | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| MAGNESIUM CARBONATE | 0E53J927NA | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
| MATRICARIA CHAMOMILLA | G0R4UBI2ZZ | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| SYMPHORICARPOS ALBUS FRUIT | 873JZU3ASZ | ACTIB |
| TOBACCO LEAF | 6YR2608RSU | ACTIB |
| GINGER | C5529G5JPQ | ACTIB |
| GOLDENSEAL | ZW3Z11D0JV | ACTIB |
| ANEMONE PULSATILLA | I76KB35JEV | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2d92c5d8-3e4b-e887-e063-6294a90ac861 | e7b49082-7cf7-7b1e-e053-2a95a90a66dc | 2025-02-07 | Warnings | e7b49082-7cf7-7b1e-e053-2a95a90a66dc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
